Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Definitive Healthcare (DH) Shares Repurchased (2021 - 2025)

Definitive Healthcare filings provide 3 years of Shares Repurchased readings, the most recent being $9.2 million for Q3 2025.

  • On a quarterly basis, Shares Repurchased rose 14.77% to $9.2 million in Q3 2025 year-over-year; TTM through Dec 2025 was $49.5 million, a 121.1% increase, with the full-year FY2025 number at $49.5 million, up 121.1% from a year prior.
  • Shares Repurchased hit $9.2 million in Q3 2025 for Definitive Healthcare, down from $19.1 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $139.0 million in Q4 2021 to a low of $7.0 million in Q2 2024.
  • Median Shares Repurchased over the past 3 years was $9.2 million (2025), compared with a mean of $30.1 million.
  • The widest YoY moves for Shares Repurchased: up 172.4% in 2025, down 14.77% in 2025.
  • Definitive Healthcare's Shares Repurchased stood at $139.0 million in 2021, then tumbled by 94.73% to $7.3 million in 2024, then increased by 25.82% to $9.2 million in 2025.
  • The last three reported values for Shares Repurchased were $9.2 million (Q3 2025), $19.1 million (Q2 2025), and $21.2 million (Q1 2025) per Business Quant data.